<?xml version="1.0" encoding="UTF-8"?>
<p id="Par19">The analytical sensitivity of the RAA assay was determined using 10-fold serial dilutions of the recombinant plasmid ranging from 10
 <sup>4</sup> to 10
 <sup>0</sup> copies/μL. A total of 50 
 <italic>M.pneumoniae</italic> strains were recovered for the specificity of the RAA assay which were collected from patients with respiratory infections at the Capital Institute of Pediatrics from 2016 to 2018. The assay specificity was also evaluated by testing other mycoplasma and bacterial infection samples containing either 
 <italic>Mycoplasma genitalium</italic> (ATCC 33530), 
 <italic>Mycoplasma hominis</italic> (ATCC 23114), 
 <italic>Mycoplasma penetrans</italic> (ATCC 55252), 
 <italic>Mycoplasma fermentans</italic> (ATCC 19989), 
 <italic>Mycoplasma hyorhinis</italic> (ATCC 17981), 
 <italic>Ureaplasma urealyticum</italic> (ATCC 27618). 
 <italic>Staphylococcus aureus</italic> (ATCC 25923), 
 <italic>Staphylococcus epidermidis</italic> (ATCC 12228), 
 <italic>Klebsiella pneumoniae</italic> (ATCC 27736), 
 <italic>Streptococcus pneumoniae</italic> (ATCC 49619), 
 <italic>Escherichia coli</italic> (ATCC 25922), 
 <italic>Legionella pneumophila</italic> (ATCC 33152), 
 <italic>Haemophilus influenzae</italic> (ATCC 43065), 
 <italic>Mycobacterium tuberculosis</italic> (ATCC 25618/H37Rv) or 
 <italic>Pseudomonas aeruginosa</italic> (ATCC27853). In addition, for the detection of serial diluted recombinant plasmid, twelve replicates were performed on five separate days to validate the reproducibility of the RAA assay.
</p>
